Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?.
Calcif Tissue Int. 103(1), 107-108.
(2018). Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment..
Hormones (Athens). 17(4), 573-579.
(2018). Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?.
Hepatology. 68(1), 389.
(2018). Outliers of bone metabolic diseases..
Metabolism. 80, 1-4.
(2018). Pharmacotherapy of type 2 diabetes: An update..
Metabolism. 78, 13-42.
(2018). Potential Impact of Active Helicobacter pylori Infection with or without Concomitant Metabolic Syndrome on Colorectal Cancer Invasion and Mortality..
Isr Med Assoc J. 20(11), 725-726.
(2018). Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology..
Dig Dis Sci. 63(4), 1087-1088.
(2018). A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration..
Neurochem Int. 113, 137-151.
(2018). Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis..
Metabolism. 87, 18-24.
(2018). Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?.
Helicobacter. 23(1),
(2018). Sarcopenic obesity..
Hormones (Athens). 17(3), 321-331.
(2018). Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead..
Metabolism. 78, A4-A9.
(2018). THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis..
Eur J Endocrinol. 179(1), R31-R45.
(2018). Thyroid dysfunction and non-alcoholic fatty liver disease..
Minerva Endocrinol. 43(3), 367-376.
(2018). Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence..
Gut Liver. 11(5), 733-734.
(2017). Adipose tissue, obesity and non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 92-108.
(2017). Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy..
Int J Cardiol. 229, 17-18.
(2017).
(2017). Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases..
J Bone Miner Res. 32(6), 1291-1296.
(2017). Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics"..
World J Gastroenterol. 23(33), 6194-6196.
(2017). Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial..
Diabetes Obes Metab. 19(12), 1805-1809.
(2017). Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 89-91.
(2017). Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?.
Int J Cardiol. 233, 92.
(2017). Helicobacter pylori on portal hypertension-related hepatic encephalopathy..
Immunopharmacol Immunotoxicol. 39(2), 105-106.
(2017). Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease..
Liver Int. 37(7), 1082.
(2017).